Latest Financial Update News

Charter Hall (ASX: CHC) has won a $1.2 billion diversified direct property mandate from an existing institutional client, reinforcing its growth trajectory in funds under management and showcasing its sector expertise across Australia.

Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.

Turners Automotive Group Limited (NZX:TRA) has announced an ordinary dividend of NZD 0.10588235 per share for the quarter ending 31 December 2025, payable on 29 April 2026, with a fully franked component and a supplementary unfranked dividend. The company offers a dividend reinvestment plan (DRP) with a 2% discount and new shares to be issued under the plan.

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

Airtasker Limited reports a strong HY26 with positive operating cash flow and robust international revenue growth, led by explosive gains in the US and UK marketplaces.

Fenix Resources Ltd has reported a remarkable half-year financial performance with revenue surging 125% and net profit soaring 419% compared to the previous year.

PWR Holdings Limited has reported a robust half-year performance with revenues climbing 27.8% and net profit rising 38.6%, underpinned by strategic expansion in motorsports and aerospace sectors. The company also announced a higher fully franked interim dividend of 3 cents per share.

PeopleIN Limited has appointed co-founder Tom Reardon as its new CEO and Managing Director, signaling continuity in leadership as the company reports a robust unaudited EBITDA of $16.1 million.

Viva Leisure has reported a robust half-year performance with underlying NPAT up 46.8% and revenue climbing to $116.5 million, driven by strong organic membership growth and a booming technology segment.

Actinogen Medical has received an additional $1.87 million R&D tax incentive rebate, bringing its total FY 2025 rebate to $7.36 million, while its Alzheimer’s phase 2b/3 trial progresses with promising safety results.

Region Group has reported a robust first half for FY26, with solid growth in funds from operations and an upgraded earnings outlook. Strategic acquisitions and portfolio management underpin its positive momentum.